Search Result "G3139/ Oblimersen"
Bcl-2 Antisense in the Treatment of Human Malignancies: A Delusion in Targeted Therapy
Journal: Current Pharmaceutical Biotechnology
Volume: 8 Issue: 6 Year: 2007 Page: 373-381
Author(s): Bjorn Tore Gjertsen, Therese Bredholt, Nina Anensen, Olav Karsten Vintermyr
Antisense Treatment in Human Prostate Cancer and Melanoma
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 6 Year: 2010 Page: 555-565
Author(s): C. Di Cresce, J. Koropatnick
Deregulation of the Mitochondrial Apoptotic Machinery and Development of Molecular Targeted Drugs in Acute Myeloid Leukemia
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 3 Year: 2008 Page: 207-222
Author(s): G. Del Poeta, A. Bruno, M. I. Del Principe, A. Venditti, L. Maurillo, F. Buccisano, R. Stasi, B. Neri, F. Luciano, A. Siniscalchi, P. de Fabritiis, S. Amadori
Targeting Bcl-2 in CLL
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 30 Year: 2012 Page: 5109-5115
Author(s): M. Rogalinska,Z.M. Kilianska
Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 1 Year: 2009 Page: 2212-2234
Author(s): Tadeusz Robak
Drugs Interfering with Apoptosis in Breast Cancer
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 3 Year: 2011 Page: 272-283
Author(s): Daniela Grimm, Markus Wehland, Jessica Pietsch, Manfred Infanger, Johann Bauer
Molecular and Genetic Profiling of Prostate Cancer: Implications for Future Therapy
Journal: Current Cancer Therapy Reviews
Volume: 3 Issue: 1 Year: 2007 Page: 25-36
Author(s): Gregory Saia, Min Zhang, Vincent Depalo, Tim Lautenschlager, Arnab Chakravarti
New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 3 Year: 2006 Page: 327-340
Author(s): Niels W.C.J. van de Donk, Andries C. Bloem, Ellen v. d. Spek, Henk M. Lokhorst
Novel Approaches to Modulate Apoptosis Resistance: Basic and Clinical Implications in the Treatment of Chronic Lymphocytic Leukemia (CLL)
Journal: Current Drug Delivery
Volume: 9 Issue: 1 Year: 2012 Page: 30-40
Author(s): Aisha Masood, Mohammad A. Shahshahan, Ali R. Jazirehi
Beneficial Outcomes of Cancer Therapeutic Modalities Based on TargetingApoptosis
Journal: Current Drug Targets
Volume: 23 Issue: 10 Year: 2022 Page: 1002-1022
Author(s): Asmaa F. Khafaga,Abd Elmonem M. Barakat,Ahmed E. Noreldin